Inogen (NASDAQ:INGN) Announces Earnings Results

Inogen (NASDAQ:INGN) announced its quarterly earnings results on Tuesday. The medical technology company reported ($0.41) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.56) by $0.15, Zacks reports. Inogen had a negative net margin of 15.89% and a negative return on equity of 27.38%.

Inogen Stock Down 3.3 %

Shares of INGN stock traded down $0.32 during mid-day trading on Tuesday, reaching $9.52. The company’s stock had a trading volume of 340,206 shares, compared to its average volume of 265,333. The firm has a market capitalization of $226.75 million, a PE ratio of -4.23 and a beta of 1.02. The company’s 50 day simple moving average is $10.19 and its 200-day simple moving average is $10.28. Inogen has a 12-month low of $5.82 and a 12-month high of $13.33.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on INGN shares. Needham & Company LLC restated a “hold” rating on shares of Inogen in a research note on Thursday, January 30th. StockNews.com upgraded Inogen from a “hold” rating to a “buy” rating in a report on Monday, February 10th.

Inogen Company Profile

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.